FDA DEVICE FACTS
ALGO 7i
Path Medical GmbH
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The ALGO® 7i Newborn Hearing Screener is a hand-held, portable hearing screener intended to objectively determine the hearing status of a newborn/infant from 34 weeks gestational age to 6 months old. Babies should be well enough for hospital discharge and should be asleep or in a quiet state at the time of screening.
Exclusion Criteria
The following criteria should be used to exclude an infant from screening with the Natus ALGO hearing screeners: « Infants not between 34 weeks gestational and 6 months of age
« Infants on ventilators or in incubators
« Infants on CNS (central nervous system) stimulants
« Infants receiving ototoxic medications
* Infants with compromised skin or jaundice
ALGO 7i devices are intended for use by audiologists, ear-nose-throat (ENT) doctors, and other hearing health care professionals, nurses and audiologically trained personnel. Basic training with the device is sufficient for performing screening of patients in good health. It is not intended to be operated by lay users.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。